20
D. D. PRIYA AND S. M. ROOPAN
[4] Khalil, E. A. G.; Nur, N. M.; Zijlstra, E. E.; El Hassan, A. M.; Davidson, R. N. Failure of a
Combination of Two Antifungal Drugs, Terbinafine plus Itraconazole, in Sudanese Post-
Kala-Azar Dermal Leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 1996, 90, 187–188. DOI:
[5] Shallal, A. H.; Muhammed, M. A. Literature Review on the Imidazole. International J.
Multidiscip. Res. Rev. 2019, 5, 1–11.
[6] Verma, A.; Joshi, S.; Singh, D. Imidazole: Having Versatile Biological Activities. J. Org.
[7] Bedi, P. M. S.; Kumar, V.; Mahajan, M. P. Synthesis and Biological Activity of Novel
Antibacterial Quinazolines. Bioorg. Med. Chem. Lett. 2004, 14, 5211–5213. DOI: 10.1016/j.
[8] Yang, W.-C.; Li, J.; Li, J.; Chen, Q.; Yang, G.-F. Novel Synthetic Methods for N-Cyano-
1H-Imidazole-4-Carboxamides and Their Fungicidal Activity. Bioorg. Med. Chem. Lett.
ꢀ
[9] Aguirre, G. 1.; Boiani, M.; Cerecetto, H.; Gerpe, A.; Gonzalez, M.; Sainz, Y. F.; Denicola,
ꢀ
A.; De Ocariz, C. O.; Nogal, J. J.; Montero, D.; et al. Novel Antiprotozoal Products:
Imidazole and Benzimidazole N-Oxide Derivatives and Related Compounds. Arch. Pharm.
[10] Carini, D. J.; Duncia, J. V.; Aldrich, P. E.; Chiu, A. T.; Johnson, A. L.; Pierce, M. E.; Price,
W. A.; Santella, J. B.; Wells, G. J.; Wexler, R. R. Nonpeptide Angiotensin II Receptor
Antagonists: The Discovery of a Series of N-(Biphenylylmethyl) Imidazoles as Potent,
Orally Active Antihypertensives. J. Med. Chem. 1991, 34, 2525–2547. DOI: 10.1021/
[11] Yang, J. J.; Landier, W.; Yang, W.; Liu, C.; Hageman, L.; Cheng, C.; Pei, D.; Chen, Y.;
Crews, K. R.; Kornegay, N.; et al. Inherited NUDT15 Variant is a Genetic Determinant of
Mercaptopurine Intolerance in Children with Acute Lymphoblastic Leukemia. JCO. 2015,
[12] Samira, I.; Patel, S.; Hasmin, M.; Patel, S. Biological Profile of Quinazoline. Int. J. Pharm.
Chem. 2012, 1, 1863–1872.
[13] Singh, V. K.; Singh, S. K.; Gangwar, L. Synthesis and Antimicrobial Activity of Novel
Fused 4-(3H) Quinazolinone Derivatives. Int. J. Recent Sci. Res 2013, 2, 425–428.
[14] Paul, R. G.; Cyrus, T.; Kate, E. J.; Kym, N. L.; Joan, M. C.; William, N.; Adrian, E. D.;
Hayley, E. B.; Boris, P.; Sandra, D.; Jonathan, B. B.; Craig, A. H..; et al. Optimization of 2-
Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral
in Vivo Activity. J. Med. Chem. 2017, 60, 1171–1188.
[15] Ghorab, M. M.; Ismail, Z.; Radwan, A. A.; Abdalla, M. Synthesis and Pharmacophore
Modeling of Novel Quinazolines Bearing a Biologically Active Sulfonamide Moiety. Acta
[16] Al-Amiery, A. A.; Kadhum, A. A. H.; Shamel, M.; Satar, M.; Khalid, Y.; Mohamad, A. B.
Antioxidant and Antimicrobial Activities of Novel Quinazolinones. Med. Chem. Res. 2014,
[17] Alagarsamy, V.; Solomon, V. R.; Dhanabal, K. Synthesis and Pharmacological
Evaluation of Some 3-Phenyl-2-Substituted-3H -Quinazolin-4-One as Analgesic, Anti-
Inflammatory Agents. Bioorg. Med. Chem. Lett. 2007, 15, 235–241. DOI: 10.1016/j.bmc.
[18] Baba, A.; Kawamura, N.; Makino, H.; Ohta, Y.; Taketomi, S.; Sohda, T. Studies on
Disease-Modifying Antirheumatic Drugs: Synthesis of Novel Quinoline and Quinazoline
Derivatives and Their Anti-Inflammatory Effect. J. Med. Chem. 1996, 39, 5176–5182. DOI:
[19] Jafari, E.; Khajouei, M. R.; Hassanzadeh, F.; Hakimelahi, G. H.; Khodarahmi, G. A.
Quinazolinone and Quinazoline Derivatives: Recent Structures with Potent Antimicrob.
Cytotoxic Act. Res. Pharm. Sci. 2016, 11, 1–14.